Controversies in Experimental Dermatology: Who is really in control of skin immunity under physiological circumstances - Lymphocytes, dendritic cells or keratinocytes?

J. M. Schröder, K. Reich, K. Kabashima, Fu-Tong Liu, N. Romani, M. Metz, A. Kerstan, P. H A Lee, K. Loser, M. P. Schön, M. Maurer, P. Stoitzner, S. Beissert, Y. Tokura, R. L. Gallo

Research output: Contribution to journalArticle

56 Citations (Scopus)

Abstract

Our views of the skin immunity theatre are undergoing constant change. These not only reflect paradigm shifts in general immunology and skin biology, but also have profound clinical implications, which call for strategic changes in dermatological therapy. Nowhere can this be witnessed at a greater level of instructiveness and fascination than when addressing the question posed by this new Controversies feature. Thus, after a very long period of dominance by T cells and Langerhans cells as 'lead actors' on the skin immunity stage, the lowly keratinocyte has recently made an astounding theatrical appearance as a key protagonist of the innate skin immunity system, which may control even acquired skin immune responses. Further enhancing dramatic complexity and tension, the mast cell has entered as an additional actor claiming centre stage, and the epidermal Langerhans cell has slipped in a surprise appearance as the chief agent of immunotolerance. May you, esteemed reader, enjoy the spectacle offered here by selected immunodermatology authorities who double as 'stage managers' pushing their respective favourite actors into the limelight. You get everything you may expect from a good performance - complete with the impresario's overture that lures you into the theatre and sets the stage, competing divas, recently discovered new talents and even the critic's digest while the performance is still ongoing. By the time the curtain drops, you will have reached your own, independent conclusions on how to answer the title question of this play - at least for the time being...

Original languageEnglish (US)
Pages (from-to)913-916
Number of pages4
JournalExperimental Dermatology
Volume15
Issue number11
DOIs
StatePublished - Nov 2006
Externally publishedYes

Fingerprint

Dermatology
Lymphocytes
Keratinocytes
Dendritic Cells
Immunity
Skin
Langerhans Cells
Theaters
Immunology
Aptitude
T-cells
Allergy and Immunology
Innate Immunity
Mast Cells
Managers
T-Lymphocytes

ASJC Scopus subject areas

  • Dermatology

Cite this

Controversies in Experimental Dermatology : Who is really in control of skin immunity under physiological circumstances - Lymphocytes, dendritic cells or keratinocytes? / Schröder, J. M.; Reich, K.; Kabashima, K.; Liu, Fu-Tong; Romani, N.; Metz, M.; Kerstan, A.; Lee, P. H A; Loser, K.; Schön, M. P.; Maurer, M.; Stoitzner, P.; Beissert, S.; Tokura, Y.; Gallo, R. L.

In: Experimental Dermatology, Vol. 15, No. 11, 11.2006, p. 913-916.

Research output: Contribution to journalArticle

Schröder, JM, Reich, K, Kabashima, K, Liu, F-T, Romani, N, Metz, M, Kerstan, A, Lee, PHA, Loser, K, Schön, MP, Maurer, M, Stoitzner, P, Beissert, S, Tokura, Y & Gallo, RL 2006, 'Controversies in Experimental Dermatology: Who is really in control of skin immunity under physiological circumstances - Lymphocytes, dendritic cells or keratinocytes?', Experimental Dermatology, vol. 15, no. 11, pp. 913-916. https://doi.org/10.1111/j.1600-0625.2006.00506_1.x
Schröder, J. M. ; Reich, K. ; Kabashima, K. ; Liu, Fu-Tong ; Romani, N. ; Metz, M. ; Kerstan, A. ; Lee, P. H A ; Loser, K. ; Schön, M. P. ; Maurer, M. ; Stoitzner, P. ; Beissert, S. ; Tokura, Y. ; Gallo, R. L. / Controversies in Experimental Dermatology : Who is really in control of skin immunity under physiological circumstances - Lymphocytes, dendritic cells or keratinocytes?. In: Experimental Dermatology. 2006 ; Vol. 15, No. 11. pp. 913-916.
@article{0ccb839aa4664c49aa5fad5ed8093905,
title = "Controversies in Experimental Dermatology: Who is really in control of skin immunity under physiological circumstances - Lymphocytes, dendritic cells or keratinocytes?",
abstract = "Our views of the skin immunity theatre are undergoing constant change. These not only reflect paradigm shifts in general immunology and skin biology, but also have profound clinical implications, which call for strategic changes in dermatological therapy. Nowhere can this be witnessed at a greater level of instructiveness and fascination than when addressing the question posed by this new Controversies feature. Thus, after a very long period of dominance by T cells and Langerhans cells as 'lead actors' on the skin immunity stage, the lowly keratinocyte has recently made an astounding theatrical appearance as a key protagonist of the innate skin immunity system, which may control even acquired skin immune responses. Further enhancing dramatic complexity and tension, the mast cell has entered as an additional actor claiming centre stage, and the epidermal Langerhans cell has slipped in a surprise appearance as the chief agent of immunotolerance. May you, esteemed reader, enjoy the spectacle offered here by selected immunodermatology authorities who double as 'stage managers' pushing their respective favourite actors into the limelight. You get everything you may expect from a good performance - complete with the impresario's overture that lures you into the theatre and sets the stage, competing divas, recently discovered new talents and even the critic's digest while the performance is still ongoing. By the time the curtain drops, you will have reached your own, independent conclusions on how to answer the title question of this play - at least for the time being...",
author = "Schr{\"o}der, {J. M.} and K. Reich and K. Kabashima and Fu-Tong Liu and N. Romani and M. Metz and A. Kerstan and Lee, {P. H A} and K. Loser and Sch{\"o}n, {M. P.} and M. Maurer and P. Stoitzner and S. Beissert and Y. Tokura and Gallo, {R. L.}",
year = "2006",
month = "11",
doi = "10.1111/j.1600-0625.2006.00506_1.x",
language = "English (US)",
volume = "15",
pages = "913--916",
journal = "Experimental Dermatology",
issn = "0906-6705",
publisher = "Wiley-Blackwell",
number = "11",

}

TY - JOUR

T1 - Controversies in Experimental Dermatology

T2 - Who is really in control of skin immunity under physiological circumstances - Lymphocytes, dendritic cells or keratinocytes?

AU - Schröder, J. M.

AU - Reich, K.

AU - Kabashima, K.

AU - Liu, Fu-Tong

AU - Romani, N.

AU - Metz, M.

AU - Kerstan, A.

AU - Lee, P. H A

AU - Loser, K.

AU - Schön, M. P.

AU - Maurer, M.

AU - Stoitzner, P.

AU - Beissert, S.

AU - Tokura, Y.

AU - Gallo, R. L.

PY - 2006/11

Y1 - 2006/11

N2 - Our views of the skin immunity theatre are undergoing constant change. These not only reflect paradigm shifts in general immunology and skin biology, but also have profound clinical implications, which call for strategic changes in dermatological therapy. Nowhere can this be witnessed at a greater level of instructiveness and fascination than when addressing the question posed by this new Controversies feature. Thus, after a very long period of dominance by T cells and Langerhans cells as 'lead actors' on the skin immunity stage, the lowly keratinocyte has recently made an astounding theatrical appearance as a key protagonist of the innate skin immunity system, which may control even acquired skin immune responses. Further enhancing dramatic complexity and tension, the mast cell has entered as an additional actor claiming centre stage, and the epidermal Langerhans cell has slipped in a surprise appearance as the chief agent of immunotolerance. May you, esteemed reader, enjoy the spectacle offered here by selected immunodermatology authorities who double as 'stage managers' pushing their respective favourite actors into the limelight. You get everything you may expect from a good performance - complete with the impresario's overture that lures you into the theatre and sets the stage, competing divas, recently discovered new talents and even the critic's digest while the performance is still ongoing. By the time the curtain drops, you will have reached your own, independent conclusions on how to answer the title question of this play - at least for the time being...

AB - Our views of the skin immunity theatre are undergoing constant change. These not only reflect paradigm shifts in general immunology and skin biology, but also have profound clinical implications, which call for strategic changes in dermatological therapy. Nowhere can this be witnessed at a greater level of instructiveness and fascination than when addressing the question posed by this new Controversies feature. Thus, after a very long period of dominance by T cells and Langerhans cells as 'lead actors' on the skin immunity stage, the lowly keratinocyte has recently made an astounding theatrical appearance as a key protagonist of the innate skin immunity system, which may control even acquired skin immune responses. Further enhancing dramatic complexity and tension, the mast cell has entered as an additional actor claiming centre stage, and the epidermal Langerhans cell has slipped in a surprise appearance as the chief agent of immunotolerance. May you, esteemed reader, enjoy the spectacle offered here by selected immunodermatology authorities who double as 'stage managers' pushing their respective favourite actors into the limelight. You get everything you may expect from a good performance - complete with the impresario's overture that lures you into the theatre and sets the stage, competing divas, recently discovered new talents and even the critic's digest while the performance is still ongoing. By the time the curtain drops, you will have reached your own, independent conclusions on how to answer the title question of this play - at least for the time being...

UR - http://www.scopus.com/inward/record.url?scp=33749166372&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749166372&partnerID=8YFLogxK

U2 - 10.1111/j.1600-0625.2006.00506_1.x

DO - 10.1111/j.1600-0625.2006.00506_1.x

M3 - Article

C2 - 17002689

AN - SCOPUS:33749166372

VL - 15

SP - 913

EP - 916

JO - Experimental Dermatology

JF - Experimental Dermatology

SN - 0906-6705

IS - 11

ER -